BML Investment Partners, L.P. 13D/13G Filings for Achilles Therapeutics plc (ACHL)

BML Investment Partners, L.P. 13D and 13G filings for Achilles Therapeutics plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-09-25
7:14 pm
Purchase
2024-09-1913GAchilles Therapeutics plc
ACHL
BML Investment Partners, L.P.4,100,002
9.970%
4,100,002increase
(New Position)
Filing